Extracellular ATP plays a role in nociceptive signalling and sensory regulation of visceral function through ionotropic receptors variably composed of P2X 2 and P2X 3 subunits. P2X 2 and P2X 3 subunits can form homomultimeric P2X 2 , homomultimeric P2X 3 , or heteromultimeric P2X 2/3 receptors. However, the relative contribution of these receptor subtypes to afferent functions of ATP in vivo is poorly understood. Here we describe null mutant mice lacking the P2X 2 receptor subunit (P2X 2 −/− ) and double mutant mice lacking both P2X 2 and P2X 3 subunits (P2X 2 /P2X 3 Dbl−/− ), and compare these with previously characterized P2X 3 −/− mice. In patch-clamp studies, nodose, coeliac and superior cervical ganglia (SCG) neurones from wild-type mice responded to ATP with sustained inward currents, while dorsal root ganglia (DRG) neurones gave predominantly transient currents. Sensory neurones from P2X 2 −/− mice responded to ATP with only transient inward currents, while sympathetic neurones had barely detectable responses. Neurones from P2X 2 /P2X 3 Dbl−/− mice had minimal to no response to ATP. These data indicate that P2X receptors on sensory and sympathetic ganglion neurones involve almost exclusively P2X 2 and P2X 3 subunits. P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice had reduced pain-related behaviours in response to intraplantar injection of formalin. Significantly, P2X 3 −/− , P2X 2 −/− , and P2X 2 /P2X 3 Dbl−/− mice had reduced urinary bladder reflexes and decreased pelvic afferent nerve activity in response to bladder distension. No deficits in a wide variety of CNS behavioural tests were observed in P2X 2 −/− mice. Taken together, these data extend our findings for P2X 3 −/− mice, and reveal an important contribution of heteromeric P2X 2/3 receptors to nociceptive responses and mechanosensory transduction within the urinary bladder.
Extracellular ATP communicates physiological signals through the activation of P2X ligand-gated cation channels and P2Y G-protein-coupled receptors. Of the seven P2X receptor subunits (P2X 1 -P2X 7 ), evidence supports a major role for P2X 2 and P2X 3 subunits in mediating the primary sensory effects of ATP (Burnstock, 2000) . P2X 3 is expressed almost exclusively on small-to-medium diameter sensory neurones, while P2X 2 is expressed on medium-to-large diameter sensory neurones, and more broadly within the peripheral and central nervous system (Burnstock, 2003) . P2X 2 and P2X 3 subunits can form homomultimeric P2X 2 , homomultimeric P2X 3 , or heteromultimeric P2X 2/3 receptors, each with unique pharmacological properties. P2X 3 receptors are rapidly desensitizing, activated by α,β-methylene ATP (α,β-meATP), and antagonized by 2 ,3 -O-trinitrophenyl-ATP (TNP-ATP); while P2X 2 receptors are slowly desensitizing, insensitive to α,β-meATP, and less sensitive to TNP-ATP than P2X 3 receptors (IC 50 2 µm versus 1 nm for P2X 3 ) . P2X 2/3 receptors have similar pharmacology to P2X 3 receptors, but the slow desensitization kinetics of P2X 2 receptors. In dorsal root ganglia (DRG) sensory neurones, P2X 3 and P2X 2/3 receptors are the predominant P2X receptors (Rae et al. 1998; Burgard et al. 1999) , whereas J Physiol 567.2 in nodose sensory neurones the effects of ATP appear to be mediated by P2X 2 and P2X 2/3 receptors ; Thomas et al. 1998) . In contrast, rat and mouse autonomic ganglion neurones appear to express mainly P2X 2 receptors . Whether P2X 2 , P2X 3 and P2X 2/3 receptors account for all of the effects of ATP on sensory and sympathetic ganglion neurones remains unclear.
Numerous studies have shown that P2X 3 and P2X 2/3 receptors play a crucial role in nociception and mechanosensory transduction (Jarvis, 2003) , but few tools have been available to define the relative contribution of these receptors to specific sensory behaviours. Studies using pharmacological agents, such as the P2X 1 , P2X 3 and P2X 2/3 selective antagonist TNP-ATP (Tsuda et al. 1999a,b; Jarvis et al. 2001; Honore et al. 2002b; Ueno et al. 2003) , and the P2X 3 , P2X 2/3 selective antagonist A-317491 (Jarvis et al. 2002; McGaraughty et al. 2003; Wu et al. 2004) , have shown that peripheral and spinal P2X 3 and P2X 2/3 receptors are involved in transmitting persistent, chronic neuropathic and inflammatory pain. P2X 3 -deficient mice (Cockayne et al. 2000; Souslova et al. 2000) , and animals treated with P2X 3 -selective antisense (Honore et al. 2002a; Barclay et al. 2002; Inoue et al. 2003) or small interfering RNA (siRNA) (Dorn et al. 2004 ) revealed comparable findings. Tsuda et al. (2000) further suggested that mechanical allodynia is mediated by P2X 2/3 receptors located on capsaicin-insensitive neurones, while thermal hyperalgesia and spontaneous nocifensive behaviours are mediated by P2X 3 receptors on capsaicin-sensitive neurones. These findings suggested that P2X 3 and P2X 2/3 receptors modulate different nociceptive pathways.
P2X 3 receptors also play a role in visceral mechanosensory transduction. In the urinary bladder (Ferguson et al. 1997; Vlaskovska et al. 2001; Sun & Chai, 2002) and ureter (Knight et al. 2002) ATP is released from the urothelium upon distension. Distension leads to increased afferent nerve activity that is mimicked by ATP and α,β-meATP, and attenuated in P2X 3 -deficient mice (Vlaskovska et al. 2001; Rong et al. 2002) . ATP and α,β-meATP can directly stimulate the micturition reflex in conscious rats, and this is inhibited by TNP-ATP (Pandita & Andersson, 2004) . Moreover, P2X 3 -deficient mice have reduced urinary bladder reflexes (Cockayne et al. 2000) . Within the gastrointestinal tract, ATP and α,β-meATP excite extrinsic (Kirkup et al. 1999; Wynn et al. 2003) and intrinsic (Burnstock, 2001; Bertrand & Bornstein, 2002; Bian et al. 2003) afferents, and P2X 3 -deficient mice have impaired peristalsis (Bian et al. 2003) .
In the present study, we generated P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice to characterize further the P2X subunits mediating ATP responses in sensory and autonomic ganglia, and to further assess the role of P2X 2 and P2X 3 subunits in pain-related behaviours and urinary bladder reflexes. We have compared these findings to P2X 3 −/− mice. Our studies confirm an important role for both P2X 2 and P2X 3 subunits in sensory afferent signalling in multiple physiological systems.
Methods

Generation of P2X 2
−/− and P2X 2 /P2X 3 Dbl−/− mice The P2X 2 gene was cloned from a 12 kb EcoR1 fragment derived from a mouse embryonic stem (ES) cell 129Ola BAC genomic library (Genome Systems, St Louis, MO, USA). The P2X 2 targeting vector includes a total of 8.0 kb of genomic sequence, a LoxP-flanked neomycin-resistance gene (Neo), and the HSV-TK gene.
Homologous recombination between the targeting vector and the wild-type P2X 2 allele results in deletion of a 2.6 kb region of the P2X 2 gene encompassing exons 2-11, and replacement of this sequence with the LoxP-flanked Neo gene. A NotI linearized targeting vector was electroporated into 129Ola-derived E14-1 ES cells, and clones were selected in 310 µg ml −1 active G418 (Invitrogen, Rockville, MD, USA) and 2 µm gancyclovir (Roche Pharmaceuticals). Southern blot analysis using a 5 flanking region probe identified positive clones with the predicted 12 and 7 kb EcoRI fragments diagnostic of the wild-type and mutant P2X 2 alleles. Targeted clones were injected into C57BL/6 J (Jackson Laboratory, Bar Harbour, ME, USA) blastocysts and germline transmission of the targeted allele was established by mating the resulting male chimeras to C57BL/6 J females. P2X 2 wild-type and mutant lines were generated on a mixed 129Ola × C57BL/6 J genetic background according to the strategy described at the Banbury Conference on Genetic Background in Mice (Silva et al. 1997) . Briefly, F2 P2X 2 homozygous mutant mice were generated by intercrossing F1 agouti heterozygotes. In contrast, F2 wild-type controls were produced by intercrossing F1 agouti wild-type mice and screening for F2 progeny in which the P2X 2 locus is homozygous for the 129Ola genetic background (i.e. derives from the genetic background of the ES cell). F2129Ola/129Ola P2X 2 wild-type mice were identified using a PCR assay that distinguishes a sequence polymorphism upstream of the P2X 2 gene between 129Ola and C57BL/6 J strains. The primers used for this assay were: P2X 2 5 901S, 5 -CCT TCT GAG TGT GAG GAT GAG-3 ; and P2X 2 5 1181AS, 5 -CAT ACT TAG CAA CCT GCC TAT C-3 . The assay generated amplicons of 280 and 305 bp for the 129Ola and C57BL/6 J alleles, respectively. F2 P2X 2 wild-type mice (129Ola/129Ola at the P2X 2 locus), and F2 P2X 2 homozygous mutant mice (129Ola × C57BL/6 J) were used to establish homozygous wild-type and mutant breeding colonies. All studies were performed on F3 mice derived from these crosses. For Southern blot genotyping assays, an internal exon 1 probe was used with a BglII digest (6.7 kb wild-type and 5.0 kb mutant allele) and an EcoRI digest (12 kb wild-type and 7.0 kb mutant allele). In addition, a three-primer PCR assay was used that generated amplicons of 194 and 350 bp for the P2X 2 wild-type and mutant alleles, respectively. The primers were as follows: P2X 2 EX11288S, 5 -GTG CAG  CTG CTC ATT CTG CTT-3 ; P2X 2 EX2482AS, 5 -CTG  CAC GAT GAA GAC GTA CCT-3 ; NEO2S, 5 -ACG AGT  TCT TCT GAG GGG ATC GGC-3 . P2X 2 /P2X 3 Dbl−/− mice were generated by crossing 129Ola × C57BL/6 P2X 3 −/− F2 mice (Cockayne et al. 2000) to 129Ola × C57BL/6 J P2X 2 +/− F2 mice to generate P2X 2 /P2X 3 compound heterozygotes. Compound heterozygotes were bred to generate homozygous P2X 2 /P2X 3 double wild-type and double knockout mice. All mice used for studies were derived from subsequently established homozygous breeding pairs, and are designated P2X 2 /P2X 3 Dbl+/+ and P2X 2 /P2X 3 Dbl−/− mice. The only exceptions are the wild-type controls used for formalin studies on P2X 2 /P2X 3 Dbl−/− , where B6129PF2/J mice from The Jackson Laboratory were used in place of homozygous-derived P2X 2 /P2X 3 Dbl+/+ . All animal use procedures were overseen and approved by the Roche Palo Alto Institutional Animal Care and Use Committee, or by the UK Home Office.
Histopathology and immunohistochemistry
For histopathology, organs were fixed in 10% formalin, embedded in paraffin, and sectioned at 5 µm. Sections were stained with haematoxylin and eosin, and examined under a light microscope. For immunohistochemistry, adult mice were killed by CO 2 inhalation. DRG, nodose ganglia, trigeminal ganglia and superior cervical ganglia (SCG) were dissected and immersed in 4% paraformaldehyde and 0.2% saturated picric acid in 0.1 m phosphate-buffered saline (PBS, pH 7.2) for 4 h. Tissues were saturated with 20% sucrose in PBS, after which the ganglia were rapidly frozen, cut into 10 µm sections, and thaw-mounted on poly-l-lysine-coated slides. For immunofluorescence double labelling, sections were incubated in 10% normal horse serum in PBS for 30 min at room temperature, followed by incubation with a rabbit polyclonal antibody against the rat P2X 2 receptor subtype (Roche) (1 : 800) in 10% normal horse serum and 0.1% Triton X-100 in PBS overnight. Sections were then incubated with biotinylated donkey anti-rabbit IgG (Jackson ImmunoResearch, West Grove, PA, USA) (1 : 500) for 1 h, extravidin peroxidase (1 : 1500) for 1 h, biotinyl tyramide for 8 min, and Streptavidin fluorescein (1 : 200) for 10 min. A rabbit polyclonal antibody against the P2X 3 receptor subtype (Roche) (1 : 400) was applied as a second primary antibody and detected with Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch). The sections were washed and mounted in citifluor.
Compounds used
Atropine, ATP, β,γ -methylene ATP (β,γ -meATP), α,β-meATP, carbachol, dimethylphenylpiperazinium (DMPP), histamine, 5-HT, substance P, γ -aminobutyric acid (GABA) and tetrodotoxin (TTX) were obtained from Sigma Chemical Company (Poole, UK). Pyridoxal-5-phosphate-6-azophenyl-2 ,4 -disulphonic acid (PPADS) (tetrasodium salt) was supplied by Tocris Cookson Ltd (Bristol, UK). TNP-ATP was obtained from Molecular Probes (Leiden, Netherlands). Stock solutions of drugs were prepared using deionized H 2 O and stored frozen. diinosine pentaphosphate (Ip 5 I) was prepared by enzymatic degradation of diadenosine pentaphosphate (Ap 5 A) (King et al. 1999) .
Primary cell culture and electrophysiology
Single neurones from DRG, nodose, SCG and coeliac ganglia of 6-to 8-month-old mice were enzymatically isolated as previously described (Zhong et al. 1998) . Briefly, mice were killed by CO 2 inhalation. Ganglia were rapidly dissected and placed in Leibovitz's L-15 medium (Life Technologies, Paisley, UK). Ganglia were desheathed, cut and incubated in 4 ml Ca 2+ /Mg 2+ -free Hanks' balanced salt solution with 10 mm Hepes buffer (pH 7.0) (HBSS) (Life Technologies) containing 1.5 mg ml −1 collagenase (Class-II; Worthington Biochemical Corporation, Reading, UK) and 6 mg ml −1 bovine serum albumin (Sigma) at 37
• C for 40 min. Ganglia were then incubated with 4 ml HBSS containing 1 mg ml −1 trypsin (Sigma) at 37
• C for 20 min. The solution was replaced with 3 ml of growth medium comprising L-15 medium supplemented with 10% bovine serum, 50 ng ml −1 nerve growth factor, 0.2% NaHCO 3 , 5.5 mg ml −1 glucose, 200 IU ml −1 penicillin and 200 µg ml −1 streptomycin. The ganglia were dissociated into single neurones by gentle trituration. The cells were then centrifuged at 160 g for 5 min, resuspended in 1 ml of growth medium, and plated onto 35 mm Petri dishes coated with 10 µg ml −1 laminin (Sigma). Cells were maintained at 37
• C in a humidified atmosphere containing 5% CO 2 , and used between 2 and 48 h after plating.
Whole-cell voltage-clamp recordings were performed at room temperature using an Axopatch 200B amplifier (Axon Instruments, Union City, CA, USA). Membrane potential was held at −60 mV. The external solution contained (mm): 154 NaCl, 4.7 KCl, 1.2 MgCl 2 , 2.5 CaCl 2 , 10 Hepes, 5.6 glucose, and the pH was adjusted to 7.4 using NaOH. Recording electrodes (resistance 2-4 M ) were filled with an internal solution which contained (mm): 56 citric acid, 3 MgCl 2 , 10 CsCl, 10 NaCl, 40 Hepes, 0.1 EGTA, 10 tetraethylammonium chloride, and the pH was adjusted to 7.2 using CsOH (total Cs + concentration 170 mm). Series resistance compensation of 72-75% was J Physiol 567.2 used in all recordings. The threshold for the minimum detectable response was set as 10 pA. Data were acquired using pCLAMP software (Axon Instruments). Signals were filtered at 2 kHz (−3 dB frequency, Bessel filter, 80 dB decade −1 ). For nodose, SCG and coeliac neurones, compounds were applied by gravity flow from independent reservoirs through a 7-barrel manifold comprising fused glass capillaries inserted into a common outlet tube (tip diameter of ∼200 µm) which was placed about 200 µm from the cell (Dunn et al. 1996) . One barrel was used to apply drug-free solution to enable rapid termination of drug application. Solution exchange measured by changes in open tip current was complete in 200 ms; however, complete exchange of solution around an intact cell was slower (≤1 s). For DRG neurones, drugs were applied through a similar 4-barrel manifold controlled by computer-driven solenoid valves. The exchange of solution around the cell was complete in ≤100 ms. The intervals between agonist applications were 2 min for nodose, SCG and coeliac ganglia neurones, and 3.5 min for DRG neurones. These were sufficient to achieve reproducible responses. All drugs were prepared from stock solutions and diluted in extracellular bathing solution to the final concentration. Traces were acquired using Fetchex (pCLAMP software) and plotted using Origin (Microcal, Northampton, MA, USA).
Nociceptive behavioural testing
The effect of a subplantar injection of P2 receptor agonists or 5% formalin was performed as described (Cockayne et al. 2000) . Mice were injected intradermally in the plantar surface of one hindpaw using a 30 g needle with varying doses of ATP or α,β-meATP in a total volume of 30 µl, or 5% formalin in a total volume of 20 µl. For P2X agonists, the total time spent lifting the treated paw in a 4 min time bin was measured. For formalin testing, the total time spent licking, biting or flinching the treated paw was measured every 5 min between 0 and 30 min. All animals were killed at the end of the study. The investigator was blinded to the identity of all animals. 
Bladder in vitro pharmacology
For in vitro tissue bath studies, mice were killed and urinary bladders were dissected into a modified Krebs solution. The tissues were viewed under a dissecting microscope, stripped of adhering fat and connective tissue, and cut to give two strips of detrusor muscle, approximately 10 × 2 mm, from each bladder. Detrusor strips were weighed and prepared for isolated organ bath recording using a dissecting microscope. Silk ligatures were applied to each end of the strip; one end was attached to a rigid support and the other end to an FT03C force displacement transducer. Each strip was suspended in a 10 ml organ bath containing gassed (95% O 2 and 5% CO 2 ) modified Krebs solution of the following composition (mm): 133 NaCl, 4.7 KCl, 16.4 NaHCO 3 , 0.6 MgSO 4 , 1.4 NaH 2 PO 4 , 7.7 glucose and 2.5 CaCl 2 , pH 7.3. Experiments were performed at 37 ± 1
• C. Separate experiments were performed to study electrical field stimulation (EFS) of the parasympathetic nerves and the action of exogenously applied agonists. Mechanical activity was recorded using the software PowerLab Chart for Windows (version 4; ADInstruments, Castle Hill, NSW, Australia). An initial load of 1 g was applied to the detrusor strips, which were then allowed to equilibrate for not less than 45 min prior to the start of the experiment. The contraction due to a standard concentration of KCl (120 mm) was noted at the end of each experiment. All compounds were prepared from stock solutions and added to the organ bath (volume, 100 µl) to produce the final concentration.
Frequency-response curves to EFS were constructed for detrusor strips (100 V, 0.3 ms, 0.5-32 Hz, 15 s stimulation every 5 min) in the absence of antagonists, and then in the presence of either PPADS (30 µm, one detrusor strip from each bladder) or atropine (1 µm, one detrusor strip from each bladder). The frequency-response curves were then repeated in the presence of both PPADS (30 µm) and atropine (1 µm). All antagonists were incubated for 20 min. The curves were finally repeated in the presence of tetrodotoxin (TTX, 1 µm for 20 min). Detrusor responses to EFS are expressed as means ± s.e.m. of the percentage maximum control response for n = 5-6 determinations.
Non-cumulative concentration-response curves were constructed for various agonists including carbachol (0.01-300 µm, n = 5-11), β,γ -meATP (0.1-300 µm, n = 5-7), and ATP (0.1 µm-1 mm, n = 5-6), and contractile responses are expressed as means ± s.e.m.
of the percentage of the KCl (120 mm) contraction for n determinations. The time interval between application of β,γ -meATP and ATP was 15-20 min to avoid desensitization. Since the concentration-response curves to these agonists did not reach a maximum, it was not possible to calculate pD2 values (−log EC 50 concentration). Contractile responses to single concentrations of substance P (0.3 µm, n = 6-18), 5-HT (100 µm, n = 4-17), and histamine (100 µm, n = 4-16) were also determined, and are expressed as means ± s.e.m. of the milligrams of tension developed for n determinations.
For in vitro pharmacology, statistical significance between individual groups of mice was tested by a two-way analysis of variance (ANOVA) followed by a post-hoc test. Statistical significance between single concentrations of substance P, 5-HT, and histamine for individual groups of mice was tested using a one-way ANOVA followed by Bonferroni's post-hoc analysis.
Mouse cystometry
Mice were anaesthetized with urethane, and transurethral closed cystometry was conducted as previously described (Dmitrieva et al. 1997; Cockayne et al. 2000) . The bladder was cannulated transurethrally with a PE-10 polypropylene catheter. A ventral midline laparotomy was performed to confirm complete bladder emptying. Each cystometrogram consisted of slowly filling the bladder with normal saline through the transurethral catheter at a rate of 10 µl min −1 , to a total volume of 0.4 ml. The filling rate was controlled by an infusion pump (Harvard Apparatus, Holliston, MA, USA), and the pressure associated with filling was recorded via a pressure transducer using PowerLab (ADInstruments). Contractions greater than 20 cm of H 2 O were taken as micturition contractions. For each cystometrogram, the volume at which active contractions occurred (micturition threshold) and the number of contractions per cystometrogram were recorded. The investigator was blinded to the identity of all animals.
Bladder afferent nerve recordings
The mouse urinary bladder/pelvic nerve preparation has been previously described in detail (Vlaskovska et al. 2001) . Briefly, the whole urinary tract attached to the lower vertebrae and surrounding tissues was isolated en bloc and superfused in a recording chamber with oxygenated (5% CO 2 and 95% O 2 ) Krebs solution (mm: 120 NaCl, 5.9 KCl, 1.2 NaH 2 PO 4 , 1.2 MgSO 4 , 15.4 NaHCO 3 , 2.5 CaCl 2 , and 11.5 glucose) at ∼26
• C. The bladder was catheterized through the urethra and connected to a syringe-type infusion pump (sp210iw; World Precision Instruments, Sarasota, FL, USA) for intraluminal infusion with Krebs (0.1 ml min −1 ). Another double-lumen catheter was inserted into the bladder through a small cut on the bladder dome for measurement of intraluminal pressure and for drainage. Both catheters were secured in place with fine sutures.
With the aid of a dissecting microscope, the pelvic nerve exiting the vertebrae was dissected. Normally, 3-4 nerve branches could be identified at this location and the finest branch was recorded with a suction glass electrode (tip diameter, ∼50 µm). The electrode was connected to a NeuroLog head stage (NL 100; Digitimer, UK) and an AC amplifier (NL 104; Digitimer, UK). Signals were amplified (×10 000), filtered (band-pass 200-4000 Hz), and acquired by a computer (sampling frequency 20 000 Hz) with a power 1401 A/D interface and Spike2 software (Cambridge Electronic Design, Cambridge, UK). The nerve activity was counted and plotted as rate histogram.
Following a 60 min stabilization period, repeated ramp distensions (0.1 ml min −1 , up to 50 mmHg) were performed at intervals of 10-15 min. The afferent response to distension was initially variable but usually became stabilized after three to five distensions. This stabilized afferent response was used for comparing mechanosensitivity of bladder afferents among different mouse genotypes. The volume and pressure threshold for whole nerves could be determined as the bladder afferents had no spontaneous activity with the bladder empty (e.g. Fig. 10 , top panel, NA trace). In many preparations, single-unit activity could be discriminated based on the amplitude and shape of individual waveforms (e.g. Fig. 10 , top panel, insert). The afferent activity at different pressure levels was determined using a script for Spike2 and the pressure-response curve was plotted in Graphpad using the Boltzmann sigmoidal equation. Values are expressed as means ± s.e.m., and the statistical significance between genotypes was compared using ANOVA.
Results
Generation and general characterization of P2X 2
−/−
and P2X 2 /P2X 3 Dbl−/− mice Mice carrying a targeted deletion in exons 2-11 of the P2X 2 gene were generated using the gene targeting strategy shown in Fig. 1A and B). P2X 2 heterozygous (P2X 2 +/− ) mice developed normally, but when intercrossed produced fewer than expected P2X 2 −/− mice (18% versus the expected 25% by Mendelian distribution, n = 794, P < 0.0001, χ 2 test). Although P2X 2 −/− mice showed small differences in body weight compared with P2X 2 +/+ mice (Table 1) , these mice were visibly and histopathologically normal for up to 1 year of age. Urinalysis, blood chemistries, and peripheral blood cell J Physiol 567.2 counts were also normal and similar between P2X 2 +/+ and P2X 2 −/− mice (data not shown). Overall, these findings were similar to those observed for P2X 3 −/− mice (Table 1  and Cockayne et al. 2000) .
To further generate mice lacking both the P2X 2 and P2X 3 receptor subunits, we crossed P2X 2 +/− mice to P2X 3 −/− mice (Cockayne et al. 2000) to generate P2X 2 /P2X 3 compound heterozygotes. These mice appeared normal, but when intercrossed with each +/− and P2X 2 −/− mice using the indicated exon-1-specific probe. P2X 2 /P2X 3 double knockout mice were generated by conventional backcrossing as described in Methods. C, EcoR1 Southern blot of C57BL/6 J, P2X 2 /P2X 3 Dbl+/+ and P2X 2 /P2X 3 Dbl−/− mice probed simultaneously with a P2X 2 exon-1-specific probe and a P2X 3 5 flanking region probe (Cockayne et al. 2000) . The P2X 2 and P2X 3 wild-type alleles in the P2X 2 /P2X 3 Dbl+/+ mice are represented by the expected 12 and 3 kb fragments, respectively, and the P2X 2 and P2X 3 mutant alleles in P2X 2 /P2X 3 Dbl−/− mice are represented by the expected 7 and 1.5 kb fragments, respectively. other produced fewer than the expected 1/16 ratio of P2X 2 /P2X 3 Dbl−/− mice. P2X 2 /P2X 3 Dbl+/+ mice and the few P2X 2 /P2X 3 Dbl−/− mice that survived (Fig. 1C ) were used to establish homozygous breeding colonies. Approximately 90% of the P2X 2 /P2X 3 Dbl−/− pups died between postnatal day 7 and weaning, and they had significantly stunted growth (Table 1) , cachexia and dyspnoea. A thorough phenotypic characterization of the nonsurvival phenotype in P2X 2 /P2X 3 Dbl−/− pups will be presented elsewhere. However, the mortality observed in P2X 2 /P2X 3 Dbl−/− mice was not due to a failure of maternal nurturing or nursing. Instead, histopathological examination identified suppurative bacterial bronchopneumonia as the cause of death. In addition, all moribund mice that were examined had evidence of distended bladders, enlarged hearts, marked atrophy or hypocellularity of lymphohaematopoietic organs (e.g. bone marrow and thymus), and lack of lymphoid follicle formation in the spleen and mesenteric lymph nodes. Fourteen-day-old mice had elevated neutrophil counts and moderately decreased lymphocyte counts (data not shown). The lymphoid hypocellularity observed in 10-to 14-day-old pups was also observed in 2-to 3-day-old pups, confirming that that these changes were present from birth. In contrast, the ∼10% of the P2X 2 /P2X 3 Dbl−/− mice that survived into adulthood had normal body weights (Table 1) , and were histopathologically normal, showing no evidence of gross lymphoid organ deficits at 6 months of age. The mechanism(s) by which surviving mice may have compensated for this phenotype is not entirely clear, and is the subject of continued study. Nevertheless, surviving P2X 2 /P2X 3 Dbl−/− were used for all subsequent studies described in the present study.
As shown in Fig. 2 , immunohistochemical staining of sensory ( Fig. 2A-D) and sympathetic ( Fig. 2E and F) ganglion neurones confirmed that P2X 2 −/− mice lack P2X 2 receptor protein (Fig 2B and F) , and that P2X 2 /P2X 3 Dbl−/− mice lacked protein for both the P2X 2 and P2X 3 receptor subunits (Fig. 2D) . Despite the loss of P2X receptor subunits, histological staining indicated no apparent differences in the appearance, density or size distribution of neuronal cell bodies in sensory or autonomic ganglia in these mice (data not shown). There were also no apparent abnormalities in support cells or in the nerve roots around the ganglia (data not shown). These findings are consistent with our previous observations in P2X 3 −/− mice (Cockayne et al. 2000) .
Immunohistochemical and electrophysiological characterization of peripheral ganglion neurones from P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice Peripheral sensory and autonomic ganglion neurones differentially express P2X 2 and P2X 3 subunits, and show interspecies differences in their distribution. P2X 2 , P2X 3 and P2X 2/3 receptors are dominant in rodent sensory ganglia (North, 2002; Burnstock, 2003) , while P2X 2 receptors, and possibly a heteromeric receptor containing P2X 2 , are found in rodent autonomic ganglia North, 2002; Calvert, 2004) . Consistent with these data, P2X 2 +/+ and P2X 2 /P2X 3 Dbl+/+ mice had strong P2X 3 and P2X 2 immunoreactivity in many small-to-medium and small-to-large diameter sensory neurones, respectively, of the DRG, nodosel and trigeminal ganglia, and many neurones showed colocalization of P2X 2 and P2X 3 subunits ( Fig. 2A and C for DRG, and data not shown). In contrast, in sympathetic SCG neurones of P2X 2 +/+ mice, most neurones had P2X 2 but not P2X 3 immunoreactivity (Fig. 2E) , consistent with reports that P2X 3 subunits do not appear to be prevalent in rat and mouse autonomic ganglion neurones (Khakh et al. 1995; Zhong et al. 2000; North, 2002) .
To determine the contribution of P2X 2 and P2X 3 receptor subunits to ATP-mediated responses in distinct populations of peripheral neurones, we performed whole-cell patch-clamp analysis on dissociated sensory and sympathetic ganglion neurones from wild-type, P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice. Results were compared to whole-cell patch-clamp responses from P2X 3 −/− mice. In DRG neurones from wild-type mice, ATP and α,β-meATP typically evoked either transient (Fig. 3Aa) or sustained (Fig. 3Ab) responses, although in a few neurones composite responses with both transient and sustained components were observed (data not shown). For P2X 2 +/+ mice 81% (17/21) of the neurones tested responded to 100 µm ATP with either a transient (0.28 ± 0.05 nA, n = 12) or a sustained (1.22 ± 0.04 nA, n = 5) inward current ( Table 2 ). The remaining four neurones failed to respond. In response to 30 µm α,β-meATP, 57% (12/21) of P2X 2 +/+ DRG neurones responded with a transient response of 0.23 ± 0.05 nA, while 23% (5/21) responded with a sustained response of 0.35 ± 0.1 nA, and four cells failed to respond to this agonist (data not shown). In P2X 2 −/− neurones 70% (17/24) of the neurones gave transient currents to 100 µm ATP (0.5 ± 0.09 nA), while 20% (5/24) gave small sustained responses (0.05 ± 0.02 nA) that were significantly different from those seen in the P2X 2 +/+ DRG neurones (1.22 ± 0.38 nA, P < 0.05) (Fig. 3B and Table 2 ). In response to 30 µm α,β-meATP, 65% (15/23) of DRG neurones responded with a transient response of 0.22 ± 0.06 nA, one cell gave a sustained response of 0.02 nA, and the remaining 7/23 cells failed to respond to this agonist (Fig. 3B , and data not shown). As previously described (Cockayne et al. 2000) , all DRG neurones from P2X 3 −/− mice failed to respond to α,β-meATP (Fig. 3Ca) , and although ∼10% of neurones did respond to ATP, these were invariably of the sustained type ( Fig. 3Cb and Table 2 ).
In DRG neurones from P2X 2 /P2X 3 Dbl+/+ mice, 56% (10/18) of the neurones tested responded to 100 µm ATP with either transient (0.64 ± 0.38 nA, n = 7), or sustained (0.58 ± 0.38 nA, n = 3) inward currents ( Fig. 3A and Table 2 ). The remaining eight neurones did not respond. These neurones gave the same type of response to 30 µm α,β-meATP (Fig. 3A , and data not shown). In contrast, the majority of DRG neurones tested from P2X 2 /P2X 3 Dbl−/− mice failed to respond to ATP (Fig. 3Da and Table 2 ). No neurones (0/19) tested responded to ATP with transient currents; however, 36% (7/19) of the neurones gave small, sustained currents averaging 0.05 ± 0.02 nA (Fig. 3Db and Table 2 ). No responses to 30 µm α,β-meATP were detected, but all neurones responded to 100 µm GABA (Fig. 3Da) .
In nodose ganglion neurones from P2X 2 +/+ mice, 100% (9/9) of the neurones tested responded to 100 µm ATP and α,β-meATP with sustained inward currents averaging 3.8 ± 1 and 1.97 ± 0.6 nA, respectively (Fig. 4A top panel, and Table 2 ). In contrast, 88% (15/17) of P2X 2 −/− nodose neurones responded to ATP and α,β-meATP, but with only a rapidly desensitizing response, such that by the end of a 1 s application the response was approximately 15% of the peak amplitude (100 µm ATP, average 0.54 ± 0.12 nA; 100 µm α,β-meATP, average 0.97 ± 0.22 nA) (Fig. 4A lower panel, and Table 2 ). These remaining transient responses were sensitive to the P2X antagonists Ip 5 I (Fig. 4B and C) and TNP-ATP (Fig. 4C) . In the presence J Physiol 567.2 of 1 µm Ip 5 I, the response to 10 µm α,β-meATP was reduced by approximately 50%, while 10 nm TNP-ATP nearly abolished the response. In nodose neurones from P2X 2 /P2X 3 Dbl+/+ mice, 100% (21/21) of the neurones tested responded to 100 µm ATP with a sustained inward current (3.8 ± 0.4 nA) (Fig. 4D and Table 2 ), while in P2X 2 /P2X 3 Dbl−/− nodose neurones only 26% (7/27) of the neurones tested responded to 100 µm ATP with barely detectable currents (0.04 ± 0.01 nA) (Fig. 4D and Table 2 ). Taken together, these data indicate that P2X 2 and P2X 3 are the major P2X receptor subunits in nodose and DRG peripheral sensory neurones.
We next measured whole-cell responses to ATP in sympathetic ganglion neurones. Sustained responses to 100 µm ATP were observed in 87% (13/15) of coeliac ganglion neurones from P2X 2 +/+ mice, with a mean amplitude of 0.48 ± 0.16 nA (Table 2 ). However, none of these neurones responded to α,β-meATP (data not shown). In coeliac ganglion neurones from P2X 2 −/− mice, none of the 14 neurones tested had a detectable response to 100 µm ATP (Table 2) . A similar pattern of responses was observed in SCG neurones; 62% (29/47) of P2X 2 +/+ neurones responded to 100 µm ATP, while only 3% (1/35) of P2X 2 −/− neurones had a detectable response (29/47 averaging 0.5 ± 0.3 nA compared with 1/35 with a response of 0.14 nA) (Fig. 5 and Table 2 ). Dbl−/− (D) mice. P2X 2 and P2X 3 immunoreactivity was present in small-large and small-medium cells, respectively, in P2X 2 +/+ (A) and P2X 2 /P2X 3 Dbl+/+ (C) mice, and many DRG neurones showed colocalization of P2X 2 and P2X 3 receptors. P2X 2 immunoreactivity was absent in P2X 2 −/− mice (B), while P2X 3 immunoreactivity appeared unaltered. Both P2X 2 and P2X 3 immunoreactivity was absent in P2X 2 /P2X 3 Dbl−/− mice (D). E and F, immunofluorescence doubling labelling for P2X 2 (green) and P2X 3 (red) receptors in transverse sections (10 µm) of superior cervical ganglia (SCG) neurones from P2X 2 +/+ (E) and P2X 2 −/− (F) mice. Many SCG neurones in P2X 2 +/+ mice showed P2X 2 receptor expression (E), and this P2X 2 immunoreactivity was absent in P2X 2 −/− mice (F). Specific P2X 3 immunoreactivity was not observed in SCG neurones of either P2X 2 +/+ or P2X 2 −/− mice. Scale bars, 50 µM.
In SCG neurones from P2X 2 /P2X 3 Dbl+/+ mice, 100 µm ATP evoked a detectable sustained inward current in every neurone tested (17/17), with a mean amplitude of 0.26 ± 0.08 nA (Table 2) . Most SCG neurones from P2X 2 /P2X 3 Dbl−/− mice failed to respond to ATP, and in the 4 of 11 cells that did respond, the inward current was very small (0.016 ± 0.002 nA, n = 4) ( Honore et al. 2002a; McGaraughty et al. 2003) , but the relative contribution of homomeric P2X 3 and heteromeric P2X 2/3 receptors to this behaviour is not entirely clear. When varying doses of ATP (100 and 300 nmol) or α,β-mATP (30, 100 and 300 nmol) were injected into the hindpaw of P2X 2 +/+ and P2X 2 −/− mice, both groups of mice produced similar responses that showed a dose-related increase in the total time spent lifting the treated hindpaw (Fig. 6A) . P2X 3 -containing receptors have also been shown to play a role in both the acute (phase I) and persistent inflammatory (phase II) phases of the formalin-induced model of chemical nociception (Cockayne et al. 2000; Souslova et al. 2000; Jarvis et al. 2001; Honore et al. 2002a; McGaraughty et al. 2003) . In P2X 2 −/− mice, intradermal administration of formalin resulted in a significant attenuation of the late phase formalin response (Fig. 6B, 40% , P < 0.01), while the early phase was similar to P2X 2 +/+ mice (Fig. 6B) . In contrast, P2X 2 /P2X 3 Dbl−/− mice had significantly attenuated behavioural responses in both phase I (Fig. 6C, 26% , P < 0.01) and phase II (Fig. 6C, 37% , P < 0.05) of the formalin response. We also measured responses to noxious thermal stimuli in P2X 2 +/+ and P2X 2 −/− mice in both the plantar test and the tail-flick test, where infrared light was used as the thermal stimulus. No differences were seen between P2X 2 genotypes in these tests of acute thermal nociception (data not shown, MiniPsychoscreen test battery).
Because P2X 2 receptors are widely distributed on neurones throughout the peripheral and central nervous system, as well as on non-neuronal cells (Burnstock, 2003) , they could conceivably play a role in a broad range of behavioural and neurological functions. To assess the overall integrity of the peripheral and central nervous system, P2X 2 −/− mice were profiled in a MiniPsychoscreen battery of behavioural tests. No differences were observed between P2X 2 +/+ and P2X 2 −/− mice in terms of general sensory function and motor coordination as assessed by a neurological evaluation that included the Irwin test, visual cliff, grip strength and rotorod performance (data not shown). P2X 2 −/− mice had a tendency toward hyperactivity in the open field test and in home cage behaviours. However, they showed no altered behaviour in depression or anxiety models, including the tail suspension test, open field test and the elevated plus maze (data not shown). P2X 2 −/− mice also showed no difference from wild-type controls in response to pentylenetetrazole (PTZ)-induced seizures (data not shown), indicating that there were no gross alterations in the general excitability of the CNS. Cystometry studies were performed on P2X-deficient mice to assess the role of P2X receptor subtypes in sensory afferent signalling within the urinary bladder. Figure 7A illustrates representative cystometrograms from P2X 2 +/+ and P2X 2 −/− mice in a urodynamic model of acute cystometry performed under anaesthesia. Distension of the urinary bladder with a fixed infusion rate of saline (10 µl min −1 , 0.4 ml in 40 min) resulted in frequent micturition contractions in P2X 2 +/+ mice, but markedly reduced contractions in P2X 2 −/− mice. The volume threshold for micturition contractions was significantly increased in P2X 2 −/− mice (0.28 ± 0.02 ml compared with 0.16 ± 0.02 ml for P2X 2 +/+ mice, P < 0.01) (Fig. 7B) , while the average number of contractions mice in response to P2X agonists A, wild-type dorsal root ganglia (DRG) neurones (representative traces from P2X 2 /P2X 3 Dbl+/+ mice) responded to ATP and α,β-meATP with either rapidly desensitizing (a) or sustained (b) responses; a composite response having both rapidly and slowly desensitizing components was also observed in some neurones (data not shown). All DRG neurones examined responded to 100 µM GABA with a sustained inward current. Comparable responses were seen in DRG neurones from all wild-type lines. B, in P2X 2 −/− mice, DRG neurones all responded to ATP and α,β-meATP with rapidly desensitizing transient responses. C, in P2X 3 −/− mice, many DRG neurones failed to respond to either ATP or α,β-meATP, but did respond to 100 µM GABA (a). Other P2X 3 −/− neurones responded to ATP with a sustained inward current, but failed to respond to α,β-meATP (b). D, in P2X 2 /P2X 3 Dbl−/− mice, most DRG neurones failed to respond to ATP or α,β-meATP, but did respond to 100 µM GABA (a). A small percentage of neurones in double knockout mice gave small, very low amplitude responses to ATP (b), but did not respond to α,β-meATP (data not shown). per cystometrogram was decreased (8.9 ± 3.2 compared with 23.2 ± 4.4 for P2X 2 +/+ mice, P < 0.05) (Fig. 7C ). To directly compare urodynamic function in mice lacking P2X 2 and/or P2X 3 receptor subunits, micturition contractions were similarly measured in P2X 3 −/− and in P2X 2 /P2X 3 Dbl−/− mice. Consistent with previous findings (Cockayne et al. 2000) , an increased threshold for micturition contractions was observed for P2X 3 −/− mice (0.35 ± 0.09 ml compared with 0.12 ± 0.03 ml for P2X 3 +/+ mice, P < 0.05), while trends were observed for P2X 2 /P2X 3 Dbl−/− mice (0.22 ± 0.05 ml compared with 0.14 ± 0.04 ml for P2X 2 /P2X 3 Dbl+/+ mice, P = 0.164). A trend to decreases in the average number of contractions per cystometrogram was observed for P2X 3 −/− mice (20.0 ± 7.0 compared with 41.4 ± 10.7 for P2X 3 +/+ mice, P = 0.136) and P2X 2 /P2X 3 Dbl−/− mice (11.7 ± 5.8 compared with 32.7 ± 8.7 for P2X 2 /P2X 3 Dbl+/+ mice, P = 0.053). To ensure that the differences in urinary bladder reflex contractions observed in P2X-deficient mice (Fig. 7) were not caused by changes in the properties of the detrusor smooth muscle, we measured in vitro smooth muscle contractile responses of the urinary bladder. EFS of the urinary bladder induced parasympathetic nerve-mediated responses that were frequency dependent ( Fig. 8A-D , control response) and abolished by 1 µm TTX (data not shown) in P2X 2 , P2X 3 and P2X 2 /P2X 3 wild-type and mutant mice (Fig. 8 , and data not shown). Figure 8 illustrates representative data from P2X 2 /P2X 3 Dbl+/+ ( Fig. 8A , male; C, female) and P2X 2 /P2X 3 Dbl−/− ( Fig. 8B , male; D, female) mice, where loss of P2X 2 and P2X 3 subunits had no effect on bladder smooth muscle responses to nerve-mediated stimulation (control responses). PPADS (30 µm) caused a significant inhibition of the response to EFS stimulation in all P2X wild-type and P2X-deficient mice (Fig. 8 , and data not shown, P < 0.001). Interestingly, the PPADS-sensitive component was greater for female compared with male mice, and this was consistent for all groups of wild-type and null mutant mice (Fig. 8, and data not shown) . The subsequent addition of atropine (1 µm) caused a further, almost complete, inhibition of responses in each group (Fig. 8 and data not shown, P < 0.001). Similarly, in the presence of atropine alone (1 µm, data not shown), there was significant inhibition of nerve-mediated responses for each group of mice, both male and female, and residual responses were almost completely inhibited by the further addition of PPADS (30 µm, data not shown). No significant differences were observed in the inhibition by PPADS (30 µm) or atropine (1 µm) between the P2X wild-type and P2X-deficient mice of either sex.
We also measured detrusor smooth muscle contraction in response to a variety of agonists in P2X 2 −/− , P2X 3
and P2X 2 /P2X 3 Dbl−/− mice. Carbachol (0.01-300 µm) caused concentration-dependent contractions of the detrusor smooth muscle, and no differences were seen in the concentration response curves, or in calculated pD 2 values (−log EC 50 concentration) between male or female P2X wild-type and P2X-deficient mice (data not shown). Both ATP (0.1 µm-1 mm) and β,γ -meATP (0.1-300 µm) caused transient concentration-dependent contractions of the detrusor smooth muscle, and no differences were seen in the concentration-response curves for either of these agonists between male or female, wild-type and null mutant mice (data not shown). As neither agonist reached a maximum response, pD2 values could not be calculated. Lastly, substance P (0.3 µm), 5-HT (100 µm), and histamine (100 µm) each caused contraction of the detrusor smooth muscle, and no differences were seen between male or female P2X wild-type and P2X-deficient mice (data not shown). To further investigate the sensory role of P2X receptor subtypes within the urinary bladder, we measured the sensitivity of bladder afferents to distension in P2X-deficient mice in a urinary bladder/pelvic nerve preparation (Vlaskovska et al. 2001) . The representative traces shown in Fig. 9 illustrate the delayed afferent responsiveness to bladder distension in P2X 3 −/− , P2X 2 −/− , and P2X 2 /P2X 3 Dbl−/− mice, compared to P2X wild-type controls. Volume and pressure thresholds for afferent activation were calculated as shown in the top panel of Fig. 10 . The volume thresholds for whole-nerve activation were significantly elevated in P2X 2 −/− Figure 5 . Whole-cell patch-clamp recordings of SCG neurones from P2X 2 −/− mice in response to ATP A, SCG neurones from P2X 2 +/+ mice gave a robust sustained inward current to ATP and the nicotinic agonist DMPP, but not to α,β-meATP. B, SCG neurones from P2X 2 −/− mice responded to DMPP, but there was no response to ATP or α,β-meATP. J Physiol 567.2 mice (0.32 ± 0.05 ml compared with 0.17 ± 0.03 ml for P2X 2 +/+ mice, P < 0.05). Similarly, the volume thresholds were increased in P2X 3 −/− mice (0.38 ± 0.06 ml compared with 0.14 ± 0.02 ml for P2X 3 +/+ mice, P < 0.01), and P2X 2 /P2X 3 Dbl−/− mice (0.38 ± 0.06 ml compared with 0.13 ± 0.03 ml for P2X 2 /P2X 3 Dbl+/+ mice, P < 0.01) −/− (B, filled bars) mice (n = 9-11), or 3-to 4-month-old male P2X 2 /P2X 3 Dbl+/+ (C, open bars) and P2X 2 /P2X 3 Dbl−/− (C, filled bars) mice (n = 12) following intraplantar injection of 5% formalin in a total volume of 20 µl. Data represent the means ± S.E.M. of the total time spent licking, biting or flinching the treated paw in the 0-5 and 5-30 min time bins following administration of formalin. * P < 0.05, * * P < 0.01; Wilcoxon rank-sum exact test. (Fig. 10A) . The pressure thresholds of bladder afferents in P2X-deficient mice also appeared to be elevated, but the differences were not significant (P > 0.05) (Fig. 10B) .
We further investigated the pressure-response relationships of whole nerves and single units in P2X wild-type and P2X-deficient mice by comparing the mean levels of activity at various intraluminal pressures. At each pressure level, the mean values of whole-nerve discharge rate were lower in all P2X-deficient mice compared with P2X wild-type controls, although the difference was not statistically significant (Fig. 10C) . However, the mean values of single unit discharge rate at pressures between 20 and 50 mmHg were significantly lower in P2X-deficient mice compared with wild-type controls (Fig. 10D) . The pressure-response relationships could be fitted with a Boltzmann sigmoidal equation, and the curves for all P2X-deficient mice had shallower slopes compared with those for P2X wild-type controls.
Discussion
The present study supports several important conclusions about the role of P2X 2 and P2X 3 subunits in mediating certain sensory functions of ATP. First, electrophysiological studies indicate that P2X 2 and P2X 3 subunits account for virtually all ATP-mediated responses in mouse sensory and sympathetic ganglion neurones. Second, our data support a role for P2X 2 subunits in mediating pain-related behaviour. Lastly, the consistent finding of bladder hyporeflexia and reduced activity of pelvic afferent fibres in response to bladder filling, in mice lacking P2X 2 and/or P2X 3 receptor subunits, supports the involvement of both P2X 3 and P2X 2/3 receptors in mediating mechanosensory transduction within the urinary bladder.
Electrophysiological studies in P2X-deficient mice have helped to define the contribution of P2X 2 , P2X 3 and P2X 2/3 receptors to ATP responses on sensory and autonomic ganglion neurones. In DRG sensory neurones, ATP and α,β-meATP induce rapidly desensitizing, slowly desensitizing or biphasic currents, consistent with P2X 3 and P2X 2/3 receptors (Rae et al. 1998; Burgard et al. 1999) . Previous studies in P2X 3 −/− mice confirmed these observations (Cockayne et al. 2000; Zhong et al. 2001) , with ∼90% of DRG neurones having no response to ATP or α,β-meATP, and only a small percentage (∼12%) responding only to ATP with slowly desensitizing currents. In contrast, nodose ganglion neurones contain predominantly P2X 2 and P2X 2/3 receptors Thomas et al. 1998) , with virtually all ATP and α,β-meATP responses being slowly desensitizing. In P2X 3 −/− mice slowly desensitizing responses to α,β-meATP were lost, while sustained responses to ATP were maintained (Cockayne et al. 2000; Zhong et al. 2001) . Taken together, these data supported the idea that ATP-induced currents in DRG neurones are mediated largely by P2X 3 receptors, while in nodose neurones P2X 2 and P2X 2/3 receptors appear more important. In the present study, we extended these findings with whole-cell patch-clamp recordings from P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice. Removal of the P2X 2 subunit left only a rapidly desensitizing response in both DRG and nodose ganglion neurones in response to ATP or α,β-meATP, consistent with the loss of slowly desensitizing P2X 2 and P2X 2/3 receptors. The antagonist sensitivity of the remaining α,β-meATP response in nodose neurones was consistent with a P2X 3 receptor: greater than 50% inhibition by 1 µm Ip 5 I, and almost complete inhibition by 10 nm TNP-ATP. Finally, in P2X 2 /P2X 3 Dbl−/− mice virtually all ATP currents were lost in DRG and nodose ganglion neurones, supporting the view that P2X 2 and P2X 3 subunits are the predominant functional P2X receptors expressed in mouse sensory neurones. Sensory ganglia in P2X 2 /P2X 3 Dbl−/− mice were of normal size and −/− (n = 7), P2X 2 −/− (n = 10) and P2X 2 /P2X 3 Dbl−/− (n = 7) mice tested in parallel, under similar conditions, with their respective wild-type controls (P2X 3 +/+ and P2X 2 /P2X 3 Dbl+/+ n = 7, P2X 2 +/+ n = 11). Data represent the means ± S.E.M. * P < 0.05, * * P < 0.01; Wilcoxon rank-sum exact test.
histological appearance, with no apparent loss of neurones. The presence of a small residual sustained response to ATP in some DRG and nodose neurones from P2X 2 /P2X 3 Dbl−/− mice indicates the presence of low levels of other P2X subunits or P2Y receptors in some neurones. P2Y 1 and P2Y 2 could play a minor role as these receptors are ATP-sensitive, and have been colocalized on sensory neurones with P2X 3 and TRPV1 receptors (Ruan & Burnstock, 2003; Gerevich & Illes, 2005) . Because of the low amplitude of these responses, we have not investigated them further.
Our findings from sympathetic ganglion neurones indicate a predominant functional role for P2X 2 -containing receptors (probably P2X 2 homomultimers). Thus, absence of the P2X 2 subunit leads to an almost complete loss of ATP responses in coeliac and SCG neurones. These data are consistent with the known pharmacology of P2X receptors in cultured autonomic ganglion neurones (Khakh et al. 1995; Zhong et al. J Physiol 567.2 2000). As with sensory neurones, the presence of small ATP responses in a few sympathetic neurones suggests the presence of low levels of some other P2 receptors. Whether this expression is normally present or the result of compensatory upregulation is unclear. Studies using P2X 1 -deficient mice have suggested that P2X 1 receptor subunits can contribute to heteromultimeric P2X 2 receptors in a small population of mouse SCG neurones (Calvert, 2004) . P2X 3 and P2X 2/3 receptors are gaining recognition for their importance in facilitating pain transmission (Jarvis, 2003) , but the differential contribution of these receptors to specific pain-related behaviours is still poorly understood. An assessment of pain-related behaviours in P2X 2 −/− mice revealed deficits in nocifensive responses in the persistent, but not acute phase of the formalin model, no alterations in acute nocifensive responses to intraplantar injection of P2X agonists, and no attenuation of acute thermal nociceptive responses in the tail flick or plantar test. These data suggest that P2X 2/3 (and P2X 2 ) receptors are probably not critical to acute nociceptive responses. These data also suggest that homomultimeric P2X 3 receptors are sufficient to account for P2X 3 -dependent nocifensive responses to ATP or α,β-meATP. This is consistent with the observed deficits in P2X agonist-induced nocifensive responses in P2X 3 −/− Figure 8 . Frequency-response curves of the purinergic and cholinergic components of nerve-mediated responses in bladders of P2X 2 /P2X 3 Dbl−/− mice Representative frequency-response curves in the absence (control) and presence of PPADS (30 µM), and finally in the presence of both PPADS (30 µM) and atropine (1 µM) for (A) male P2X 2 /P2X 3 Dbl+/+ mice (n = 5), (B) male P2X 2 /P2X 3 Dbl−/− mice (n = 6), (C) female P2X 2 /P2X 3 Dbl+/+ mice (n = 5), and (D) female P2X 2 /P2X 3 Dbl−/− mice (n = 5). Electrical field stimulation (EFS) was carried out at 100 V, 0.3 ms, 0.5-32 Hz, with 15 s stimulation. Data represent the means ± S.E.M. of the percentage of the maximum control response. * * * P < 0.001; two-way analysis of variance (ANOVA).
mice (Cockayne et al. 2000) , and in rats following intraplantar administration of A-317491 (McGaraughty et al. 2003) . Inoue et al. (2003) have also shown that P2X 3 antisense inhibits multiple pain-related behaviours induced by intraplantar α,β-meATP, including nocifensive behaviour, thermal hyperalgesia and mechanical allodynia, while only the latter is inhibited by P2X 2 antisense. In addition to P2X 3 receptors, it is reasonable to speculate that additional P2X or P2Y receptors are involved in the pain-producing effects of ATP. Accordingly, the reduction in nocifensive lifting in P2X 3 −/− mice was suppressed by only ∼50%, but a further reduction in the residual response was produced by the nonselective P2 receptor antagonist PPADS (Cockayne et al. 2000) .
In the formalin model, deficits in only the persistent phase in P2X 2 −/− mice contrasts with findings from P2X 3 −/− mice (Cockayne et al. 2000; Souslova et al. 2000) , or from rats following intradermal administration of TNP-ATP or A-317491 (Jarvis et al. 2001; McGaraughty et al. 2003) , where attenuated responses were seen in both acute and persistent formalin-induced nociception. These data suggest that P2X 2/3 (and P2X 2 ) receptors are not critical to the acute nociceptive effects of formalin, but are a necessary component of the second phase of the formalin response, where they may contribute to the underlying changes in central sensitization believed to be associated with persistent inflammatory pain. These findings are consistent with the idea that presynaptic P2X 3 and/or P2X 2/3 receptors may be important in ATP-mediated facilitation of glutamate release from primary sensory afferents in the dorsal horn of the spinal cord Nakatsuka & Gu, 2001; Nakatsuka et al. 2003) . Whether homomeric P2X 2 receptors, or heteromeric receptors containing the P2X 2 subunit (other than P2X 2/3 ), also contribute to persistent pain responses is not entirely clear; however, it has been suggested that pre-and postsynaptic P2X 2 receptors may be involved in some aspects spinal nociceptive processing (Bardoni et al. 1997; Hugel & Schlichter, 2000) . It will be intriguing to determine whether the mechanism(s) underlying the potentially distinct but overlapping roles for P2X 3 and P2X 2/3 receptors reflects differential regulation of receptor function within single neurones, or rather reflects differential expression patterns within neurones playing distinct coding roles. Nevertheless, our data are consistent with recent findings (Jarvis, 2003) that P2X 3 receptors mediate some aspects of acute nociception, while P2X 2/3 receptors appear to play a more prominent role in persistent inflammatory pain and some aspects of central sensitization (e.g. neuropathic pain). Deficits in both the acute and persistent phase of the formalin response in P2X 2 /P2X 3 Dbl−/− mice are consistent with this interpretation. Studies with mice lacking P2X 2 and/or P2X 3 receptor subunits in additional models of chronic inflammatory and neuropathic pain may help elucidate this further.
P2X 3 -containing receptors also play an important role in visceral mechanosensory transduction. Within the urinary bladder, it is proposed that ATP released from the uroepithelium signals the extent of distension and activates P2X 3 receptors on adjacent primary afferent nerve fibres; thus conveying information on bladder 'fullness' to spinal and supraspinal centres coordinating the micturition reflex. Previously, we demonstrated that P2X 3 −/− mice had reduced urinary bladder reflexes (Cockayne et al. 2000) , and a delayed threshold for activation of pelvic nerve afferents in response to distension (Vlaskovska et al. 2001) . In the present study, a direct comparison of cystometric function across P2X 2 −/− , P2X 3 −/− and P2X 2 /P2X 3 Dbl−/− mice showed a consistent finding of urinary bladder hyporeflexia. Myographic responses of isolated bladders were normal in these mice, as no changes were observed in responsiveness to neurogenic stimulation, or to stimulation with a variety of neuro- Figure 9 . Pelvic nerve response to bladder filling in P2X 3 −/− , P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice Representative traces of intraluminal pressure (IP), whole-nerve activity (NA), and whole-nerve discharge rate (frequency) are shown for P2X 3 (left), P2X 2 (middle) and P2X 2 /P2X 3 Dbl (right) wild-type (upper panels) and mutant (lower panels) mice. The dotted lines indicate the start of bladder distension at a constant rate of 0.1 ml min −1 . Note the marked delay in bladder afferent activation in P2X-deficient mice.
transmitters acting via muscarinic, purinergic, histamine, or neurokinin receptors. These findings support the conclusion that bladder hyporeflexia in P2X-deficient mice results from changes in sensory and not motor function. Supporting these sensory findings, bladder afferents from P2X-deficient mice had altered electrophysiological responses, as measured by an increased threshold for activation of pelvic nerve afferents in response to bladder distension. These data extend our previous findings from P2X 3 −/− mice, and indicate that P2X 3 and P2X 2/3 receptors on bladder afferent terminals are important in mechanosensory transduction within the urinary bladder. These findings are consistent with those of Zhong et al. (2003) that bladder sensory neurones projecting via the pelvic nerve express predominantly P2X 2/3 receptors (Zhong et al. 2003) . In this study, whole-cell patch-clamp recordings of labelled bladder pelvic afferents revealed that ∼90% of bladder afferent neurones responded to ATP and α,β-meATP with persistent, TNP-ATP-sensitive currents. In the present study, single-unit activity measurements J Physiol 567.2 Figure 10 . Threshold for whole-nerve response to bladder distension and single unit discrimination reveals a reduced sensitivity of pelvic afferents in P2X-deficient mice Top panel, the upper three traces are intraluminal pressure (IP), whole-nerve activity (NA) and whole-nerve discharge rate (frequency). The lower two traces are a single-unit spike (Unit) and its discharge rate (unit frequency). In the inset are superimposed spikes of that unit showing little variation in waveform. The dotted line indicates the start of bladder filling and the second solid line indicates the start of nerve firing (pressure threshold). Volume threshold is calculated from the interval between those two lines and the rate of bladder filling (0.1 ml min −1 ). Bottom panel, reduced sensitivity of pelvic afferents to bladder filling in P2X 3 −/− , P2X 2 −/− and P2X 2 /P2X 3 Dbl−/− mice. A, volume thresholds were significantly increased in P2X-deficient mice (n = 7-10) compared with the respective wild-type controls (n = 6-12). B, pressure thresholds were not significantly different between P2X-deficient mice (n = 6-10) and wild-type controls (n = 6-9). C, the pressure-response curves of whole nerves (C) and single units (D) in P2X-deficient mice showed shallower slopes compared with wild-type mice. * P < 0.05 and * * P < 0.01 comparing the mean discharge frequency of wild-type mice with P2X-deficient mice at various intraluminal pressure levels; two way analysis of variance (ANOVA). also confirmed that afferent mechanosensitivity was reduced in P2X-deficient mice. However, additional experimentation will be needed to investigate whether P2X deletions confer changes in the sensitivity of low threshold Aδ, or high threshold C-fibre afferents. Studies in cat have shown that Aδ afferents respond in a graded manner to bladder distension, but can also be activated by noxious stimuli (Janig & Morrison, 1986) , while C fibres have high mechanical thresholds and are sensitized by inflammatory mediators (Habler et al. 1990 ). ATP and α,β-meATP not only activate both low-and high-threshold bladder afferents directly, but also sensitize their mechanosensory responses (Vlaskovska et al. 2001; Rong et al. 2002) . Thus, P2X 3 and P2X 2/3 receptors may be important in sensing volume changes during normal bladder filling, but may also participate in lowering the threshold for afferent activation in pathological circumstances.
In summary, we have demonstrated that P2X 2 and P2X 3 subunits account for virtually all ATP responses in sensory and autonomic ganglion neurones. We have also shown that in addition to P2X 3 receptors, P2X 2/3 receptors (and possibly P2X 2 ) are important in sensory modulation in at least one model of persistent pain and in the regulation of urinary bladder reflexes. While gene deletion in mice can result in compensatory changes in vivo that may contribute to observed behavioural phenotypes, our collective data on pain-related behaviours in P2X 2 −/− , P2X 3 −/− and P2X 2 /P2X 3 Dbl−/− mice are consistent with data generated using the dual P2X 3 , P2X 2/3 receptor antagonist A-317491 (Jarvis et al. 2002; McGaraughty et al. 2003; Wu et al. 2004) , P2X 3 deletion (Souslova et al. 2000) , or antisense (Honore et al. 2002a; Barclay et al. 2002; Inoue et al. 2003) and siRNA (Dorn et al. 2004 ) knock-down approaches of P2X 3 or P2X 2 receptor expression. Taken together, these data support an important role for both P2X 3 and P2X 2/3 receptors in mediating potentially distinct, but overlapping, roles in pain transmission. Given the interest in investigating selective P2X 3 and P2X 2/3 antagonists for conditions of inflammatory or neuropathic pain, and disorders of urine storage and voiding, such as overactive bladder, it will be essential to understand the differential role of these receptors in somatic and visceral mechanosensory pathways, as well as the relative importance of peripheral and central P2X 3 -containing receptors. However, evidence to date suggests that antagonism of P2X 3 and P2X 2/3 receptors s may have therapeutic potential in the treatment of these conditions.
